Medicare Enrolled
Dr. Edward Lain, M.D.
Dermatology · Austin, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lain?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lain
Dr. Edward Lain is a dermatology specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lain performed 3,825 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lain received a total of $1,927,839 from 52 pharmaceutical and/or device companies across 2229 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lain is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 33% volume in TX
$1,927,839 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,825
Medicare services
Top 33% in TX for dermatology
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,542 | $5 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
562 | $64 | $184 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
425 | $39 | $140 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
259 | $34 | $88 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
220 | $81 | $239 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
198 | $65 | $213 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
123 | $40 | $116 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
98 | $83 | $260 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
78 | $121 | $353 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
68 | $41 | $105 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $79 | $228 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
34 | $34 | $119 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
30 | $1 | $2 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
22 | $139 | $372 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
17 | $58 | $202 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
17 | $224 | $571 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
17 | $47 | $148 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
15 | $238 | $636 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
14 | $98 | $264 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
13 | $100 | $509 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $131 | $338 |
| Acne surgery A surgical procedure to treat acne. The specific techniques and extent of the surgery are not defined in this general code description. |
11 | $86 | $244 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.3% high complexity
16.7% medium
83.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,927,839
Total received (2018-2024)
Avg $275,406/year across 7 years
Top 0% in TX for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
2,229
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$500,230
2023
$507,849
2022
$321,341
2021
$159,541
2020
$132,676
2019
$248,990
2018
$57,212
Payments by company (2024)
UCB, Inc.
$110,981
E.R. Squibb & Sons, L.L.C.
$70,796
Galderma Laboratories, L.P.
$51,626
Incyte Corporation
$44,812
Ortho Dermatologics, a division of Bausch Health US, LLC
$41,044
ABBVIE INC.
$28,615
Arcutis Biotherapeutics, Inc.
$27,956
Almirall LLC
$26,400
Regeneron Healthcare Solutions, Inc.
$26,323
PFIZER INC.
$23,906
Lilly USA, LLC
$15,337
Takeda Pharmaceuticals U.S.A., Inc.
$11,415
Eli Lilly and Company
$7,219
Biofrontera Inc.
$6,041
GENZYME CORPORATION
$3,504
Janssen Global Services, LLC
$3,016
Dermavant Sciences, Inc.
$306
LEO Pharma Inc.
$292
Novartis Pharmaceuticals Corporation
$179
SUN PHARMACEUTICAL INDUSTRIES INC.
$105
REVANCE THERAPEUTICS, INC.
$95
Amgen Inc.
$94
Verrica Pharmaceuticals Inc.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$41
Organon Llc
$20
STRATA Skin Sciences, Inc.
$16
Janssen Biotech, Inc.
$16
Top 3 companies account for 46.7% of 2024 payments
All-time payments by company (2018-2024) ›
Ortho Dermatologics, a division of Bausch Health US, LLC
$293,718
Galderma Laboratories, L.P.
$262,523
Almirall LLC
$162,784
E.R. Squibb & Sons, L.L.C.
$161,820
PFIZER INC.
$139,886
UCB, Inc.
$126,211
Incyte Corporation
$99,483
Allergan, Inc.
$91,703
ABBVIE INC.
$77,223
Arcutis Biotherapeutics, Inc.
$60,263
Lilly USA, LLC
$53,710
Dermavant Sciences, Inc.
$53,398
Allergan Inc.
$49,254
Regeneron Healthcare Solutions, Inc.
$46,931
DERMIRA, INC.
$43,776
LEO Pharma Inc.
$36,292
GENZYME CORPORATION
$31,844
VYNE Pharmaceuticals Inc.
$30,870
Pfizer Inc.
$23,759
Novartis Pharmaceuticals Corporation
$14,311
Takeda Pharmaceuticals U.S.A., Inc.
$11,415
Aclaris Therapeutics, Inc.
$9,154
Biofrontera Inc.
$9,006
Eli Lilly and Company
$8,941
Sun Pharmaceutical Industries Inc.
$7,163
EPI Health, LLC
$7,092
SUN PHARMACEUTICAL INDUSTRIES INC.
$4,625
Janssen Global Services, LLC
$3,016
NOVARTIS PHARMACEUTICALS CORPORATION
$2,025
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,960
Biofrontera Bioscience GmbH
$547
AbbVie, Inc.
$545
Janssen Biotech, Inc.
$461
Merz North America, Inc.
$377
AbbVie Inc.
$357
MERZ NORTH AMERICA, INC.
$254
Vanda Pharmaceuticals Inc.
$182
Mayne Pharma Inc.
$170
Amgen Inc.
$126
Janssen Research & Development, LLC
$125
REVANCE THERAPEUTICS, INC.
$95
MAYNE PHARMA INC.
$77
Verrica Pharmaceuticals Inc.
$75
Journey Medical Corporation
$68
STRATA Skin Sciences, Inc.
$61
Pierre Fabre Pharmaceuticals, Inc.
$35
Celgene Corporation
$29
Encore Dermatology Inc.
$25
Organon LLC
$21
Organon Llc
$20
SANOFI-AVENTIS U.S. LLC
$19
Medimetriks Pharmaceuticals, Inc.
$14
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · ATRALIN · Absorica LD · Ameluz · BF-RhodoLED · BOTOX · BOTOX COSMETIC · BRYHALI · Bimzelx · CIBINQO · CLODERM · CORDRAN · COSENTYX · Cabtreo · Cimzia · DAXXIFY · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Exelderm · HADLIMA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Impoyz · JUBLIA · JUBLIA EFINACONAZOLE · Klisyri · LIBTAYO · LITFULO · LUZU · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Olumiant · Otezla · QBREXZA · REMICADE · RHOFADE · RINVOQ · RhodoLED XL · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · VTAMA · Veltin · WYNZORA · Winlevi · XEOMIN · XOLAIR · XTRAC · Xeomin · YCANTH · ZILXI · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
139
County median income
$97,169
Nearest hospital to ZIP centroid (approximate)
THE HOSPITAL AT WESTLAKE MEDICAL CENTER
7.6 mi
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lain is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lain experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Lain performed 1,542 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lain receive payments from pharmaceutical companies?
Yes. Dr. Lain received a total of $1,927,839 from 52 companies across 2,229 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lain's costs compare to other dermatologists in Austin?
Dr. Lain's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Austin
Browse dermatologists in Austin ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in TX
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in TX
Which TX dermatologists receive the most from drug and device companies.
By company
Ortho Dermatologics, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Ortho Dermatologics, a division of Bausch Health US, LLC.
By company
Galderma Laboratories, L.P. Payments to Doctors
See all physicians who received payments from Galderma Laboratories, L.P.
By company
Almirall LLC Payments to Doctors
See all physicians who received payments from Almirall LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology